MAIA Biotechnology Files 8-K

Ticker: MAIA · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1878313

Maia Biotechnology, INC. 8-K Filing Summary
FieldDetail
CompanyMaia Biotechnology, INC. (MAIA)
Form Type8-K
Filed DateJun 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-k, regulatory-filing

TL;DR

MAIA Bio filed an 8-K, but it's light on details for now.

AI Summary

MAIA Biotechnology, Inc. filed an 8-K on June 5, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only that they were reported on this date.

Why It Matters

This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, but the lack of specific details means investors cannot yet assess any immediate impact.

Risk Assessment

Risk Level: low — The filing is a standard procedural report with no new material information disclosed.

Key Players & Entities

FAQ

What specific events are being reported under "Other Events"?

The filing does not specify the nature of the "Other Events" beyond stating that they are being reported.

What are the "Financial Statements and Exhibits" being filed?

The filing indicates that financial statements and exhibits are included but does not detail their content.

What is the significance of the filing date of June 5, 2025?

June 5, 2025, is the date of the earliest event reported in this Form 8-K filing.

Where is MAIA Biotechnology, Inc. incorporated and what is its principal executive office address?

MAIA Biotechnology, Inc. is incorporated in Delaware and its principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.

What is the Commission File Number for MAIA Biotechnology, Inc.?

The Commission File Number for MAIA Biotechnology, Inc. is 001-41455.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing